During the fourth quarter of 2024, Nevro made significant advancements in its product offerings and market expansion. The ...

During the third quarter, Nevro announced the FDA approval and limited market release of HFX iQ AdaptivAI, a responsive, personalized pain management platform powering the HFX iQ SCS system.

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord ...

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord ...

About Nevro Corp. Based in Redwood City, California, Nevro is a medical device company known for its HFX spinal cord stimulation (SCS) platform. On or around December 1, 2024, Nevro detected ...

“We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering ...

NEW YORK, NY / ACCESS Newswire / April 17, 2025 / Nevro Corp., recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals ...

OKLAHOMA CITY, April 03, 2025 (GLOBE NEWSWIRE) -- Nevro Corp. investigated by Federman & Sherwood for data breach. On April 3, 2025, Nevro Corp. filed notice of a data breach with the Attorney ...

NEW YORK, NY / ACCESS Newswire / April 13, 2025 / Nevro Corp.,recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals ...